Absci Investor Presentation Deck
October 2023, 111 slides
  1. Absci
  2. Related Decks
  3. Investor Presentation Decks
| Absci
| Absci
agenda | Absci
opening remarks | Absci
overview | Absci
what if the next transformative drug was not discovered but created with a click of a button | Absci
the drug discovery paradigm is ripe for disruption a | Absci
unlocking the potential of generative in biology requires scalable biological data | Absci
is solving the problem of scalable biological data enabling true generative for drug discovery | Absci
integrated drug creation platform | Absci
is the first to design and validate novel antibodies using zero shot generative | Absci
the leading full stack platform for drug creation | Absci
potential to unlock new and differentiated value drivers | Absci
team of innovators and to achieve the impossible wir ire | Absci
increasing momentum to revolutionize drug creation | Absci
the drug creation revolution is only just beginning a | Absci
recent updates new today | Absci
business updates | Absci
topics | Absci
professional background | Absci
why | Absci
organizational highlights shire | Absci
state of the art facilities infrastructure | Absci
improving efficiency | Absci
integrated drug creation platform process | Absci
potential to unlock new and differentiated value drivers | Absci
potential to unlock new and differentiated value drivers | Absci
potential to unlock new and differentiated value drivers | Absci
potential to unlock new and differentiated value drivers | Absci
potential to unlock new and differentiated value drivers | Absci
accelerating time to clinic while increasing probability of success better for patients faster | Absci
ultra efficient generation | Absci
we are leveraging our platform advantages to create internal programs | Absci
internal program partnerships have attractive risk return profiles | Absci
recent data illustrate increase in deal economics associated with additional internal development | Absci
business model evolution a | Absci
metrics a internal programs announced today new active programs projected this year | Absci
what next be | Absci
innovation | Absci
professional background shire | Absci
innovation leadership team with outstanding track record | Absci
why | Absci
capability overview the leading platform for drug creation so | Absci
today focus platform and internal drug creation portfolio | Absci
break | Absci
partner presentation | Absci
day a generative for life sciences | Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
| Absci
platform | Absci
topics background motivations therapeutic antibodies lead optimization using | Absci
professional background | Absci
why | Absci
antibody development using generative | Absci
drug creation with zero shot generative | Absci
design of her antibodies | Absci
data highlights gore | Absci
data highlights | Absci
scaling our development with high throughput validation | Absci
leveraging wet lab and for parametric lead optimization | Absci
from designs to optimized therapeutics | Absci
valent lead optimization towards a broad spectrum antibody | Absci
generate information rich libraries for model training | Absci
ace assay platform generates large high quality training sets enabling in silico affinity predictions | Absci
model searches mutational space and top predictions are validated | Absci
optimized binding to multiple variants | Absci
optimization for dual or valent increases potential optimization i | Absci
industry leading drug creation platform for | Absci
drug creation | Absci
professional background | Absci
topics drug creation portfolio reverse immunology platform | Absci
internal pipeline bowel | Absci
a antagonism has the potential to become a blockbuster in inflammation and fibrosis | Absci
major milestone in successfully applying on pipeline asset | Absci
design of potential best in class a antagonist | Absci
dermatology portfolio | Absci
harnessing the human adaptive immune response to identify novel targets and therapeutics | Absci
antibodies selected in tertiary lymphoid structures bind to cancer cells and are associated with favorable clinical outcomes earn go of | Absci
our integrated identifies antigens targeted by exceptional immune response | Absci
discovery of a novel mechanism of tumor immune evasion using reverse immunology me be | Absci
target identification reveals potent and specific binding to an undisclosed target | Absci
inhibits a potential immune evasion switch | Absci
has a broad potential in oncology | Absci
internal pipeline | Absci
this revolution is only just beginning | Absci
a | Absci
thank you this revolution is only just beginning volution | Absci
See More
Absci
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Drug discovery
Recent decks by Absci
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
October 2023
Investor Presentation
July 2023
See all presentations by Absci (12 decks)
Related decks
BenevolentAI
Investor Presentation
September 2024
Relay Therapeutics
IPO
July 2020
Evotec
Investor Presentation
July 2022
23andMe
Investor Day
January 2022
Exscientia
Investor Day
January 2024
BenevolentAI
Investor Presentation
October 2022
AbCellera
Investor Presentation
May 2023
ATAI
Investor Presentation
June 2020
Recent decks by Absci
See all presentations (12 decks)
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
October 2023
Investor Presentation
July 2023
BenevolentAI
Investor Presentation
September 2024
Relay Therapeutics
IPO
July 2020
Evotec
Investor Presentation
July 2022
23andMe
Investor Day
January 2022
Exscientia
Investor Day
January 2024
BenevolentAI
Investor Presentation
October 2022
AbCellera
Investor Presentation
May 2023
ATAI
Investor Presentation
June 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights